KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?

Figure 1

Immunohistochemical analysis of KRAS mutated colorectal cancer with absence of staining, ×50 HPF.